109132 ⎘
Structure or type of the nucleic acid; Type of nucleic acid Antisense
COMPOUNDS AND METHODS FOR MODULATION OF SMN2
#2402Methods for promoting reinnervation of auditory hair cells
#2403Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies
#2404Pharmaceutical compositions and methods for potentiating gene silencing
#2405Oligonucleotide compositions with enhanced efficiency
#2406ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS
#2407Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
#2408Methods for creating integration-free, virus-free, exogenous oncogene-free IPS cells and compositions for use in such methods
#2409Antisense nucleic acids
#2410TREATMENT OF HORMONAL DISORDERS OF GROWTH
#2411ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING
#2412Oligonucleotides for inducing paternal UBE3A expression
#2413Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down
#2414Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease
#2415Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#2416Antisense oligonucleotides
#2417Method for the diagnosis, prognosis and treatment of cancer metastasis
#2418Antiviral agents
#2419Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
#2420Compounds and methods for enhanced cellular uptake
#2421CCCTC-binding factor (CTCF) RNA interactome
#2422Compositions and methods for reducing neointima formation
#2423Compositions and methods for treating cancer
#2424Use of leucine-zipper protein for diagnosis or treatment of fatty liver
#2425Recombinant virus products and methods for inhibition of expression of DUX4
#2426DEVELOPMENT OF FUNGAL RESISTANT CROPS BY HIGS (HOST-INDUCED GENE SILENCING) MEDIATED INHIBITION OF GPI-ANCHORED CELL WALL PROTEIN SYNTHESIS
#2427Compositions for transfecting resistant cell types
#2428Methods of identifying and treating poor-prognosis cancers
#2429RNAi agents for Hepatitis B virus infection
#2430METHOD FOR EFFICIENT EXON (44) SKIPPING IN DUCHENNE MUSCULAR DYSTROPHY AND ASSOCIATED MEANS
#2431SPINAL MUSCULAR ATROPHY (SMA) TREATMENT VIA TARGETING OF SMN2 SPLICE SITE INHIBITORY SEQUENCES
#2432Processes for preparing phosphorodiamidate morpholino oligomers
#2433Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2434DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
#2435MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD
#2436Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
#2437SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#2438CANCER TREATMENT BY GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1 INHIBITION
#2439Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
#2440Cancer Treatment and Immune System Regulation Through FAT10 Pathway Inhibition
#2441SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#2442Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs
#2443Crosslinked micellar spherical nucleic acids
#2444CAMK2D antisense oligonucleotides and uses thereof
#2445METHODS OF TREATEMENT OF CANCER DISEASE BY TARGETTING TUMOR ASSOCIATED MACROPHAGE
#2446Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2447COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF TARGET POLYNUCLEOTIDES FROM LEPIDOPTERA
#2448Chimeric double-stranded nucleic acid
#2449Antisense molecules and methods for treating pathologies
#2450Antisense compounds and uses thereof
#2451THERAPEUTIC AGENT FOR PERIODONTITIS AND COMPOSTION FOR TREATING PERIODONTITIS
#2452Polymerizable compound, compound, and method for producing boranophosphate oligomer
#2453Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof
#2454Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2455Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2456Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2457Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2458Inhibiting microRNA to prevent development of essential hypertension
#2459Modulation of gene expression and screening for deregulated protein expression
#2460Compositions for modulating C9ORF72 expression
#2461Generic System of Antisense Oligonucleotide
#2462TGF-beta oligonucleotide for use in treatment of ophthalmic diseases
#2463Treatments of non-alcoholic steatohepatitis (NASH)
#2464Compositions comprising antisense-encoded erythropoietin receptor and use thereof
#2465ANTAGONIST OF MINERALOCORTICOID RECEPTOR FOR THE TREATMENT OF OSTEOARTHRITIS
#2466Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2467Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2468Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2469AAV delivery of shRNA for treatment of pancreatic cancer
#2470Antisense oligonucleotides for the treatment of eye disease
#2471Modulation of TJP1 expression to regulate regeneration of heart cells
#2472RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION
#2473Methods for creating bilayers for use with nanopore sensors
#2474Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skipping
#2475Modulation of huntingtin expression
#2476C/EBPα short activating RNA compositions and methods of use
#2477Antisense compounds and uses thereof
#2478Branched oligonucleotides
#2479Compounds and methods for reducing ATXN3 expression
#2480IDENTIFICATION AND USE OF TARGET GENES FOR CONTROL OF PLANT PARASITIC NEMATODES
#2481Antisense oligonucleotides useful in treatment of Pompe disease
#2482Modulators of DNM2 expression
#2483MOLECULAR RE-ENGINEERING OF EXCITATION-INHIBITION BALANCE IN MEMORY CIRCUITS
#2484METHODS AND COMPOSITIONS FOR MANIPULATING TRANSLATION OF PROTEIN ISOFORMS FROM ALTERNATIVE INITIATION START SITES
#2485Methods of treating a wound using epigenetic regulation
#2486Modulation of prekallikrein (PKK) expression
#2487MODULATORS OF GROWTH HORMONE RECEPTOR
#2488CTLA-4-targeting trans-splicing ribozyme for delivery of chimeric antigen receptor, and use thereof
#2489MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#2490GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#2491Let-7 microRNA and mimetics thereof as therapeutics for cancer
#2492Chemically modified single-stranded RNA-editing oligonucleotides
#2493Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#2494Antisense nucleic acids
#2495TMPRSS6 iRNA compositions and methods of use thereof
#2496Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#2497Modulators of telomere disease
#2498Anti-TNF compounds
#2499Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#2500COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION
#2501RNA PRODUCTS AND USES THEREOF
#2502COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY
#2503Antisense nucleic acids
#2504Antisense nucleic acids
#2505Method of Modulating Fibroblast Accumulation or Collagen Deposition
#2506Carboxylated 2′-amino-LNA nucleotides and oligonucleotides comprising the same
#2507METHOD OF TREATING SYSTEMIC FIBROTIC DISORDERS USING AN IL-33/TNF BISPECIFIC ANTIBODY
#2508Modulators of vault RNAs for use in the treatment of diseases
#2509Antisense-induced exon exclusion in type VII collagen
#2510Nicking and extension amplification reaction (NEAR) of respiratory syncytial virus species
#2511Modulation of GYS1 expression
#2512Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#2513Natural cryptic exon removal by pairs of antisense oligonucleotides
#2514Inhibitors of SRSF1 to treat neurodegenerative disorders
#2515ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#2516Anti-connexin compounds targeted to connexins and methods of use thereof
#2517RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
#2518THERAPEUTIC USES OF LAG3 THE (alpha)-SYNUCLEIN TRANSMISSION RECEPTOR
#2519Lipid-derived neutral nanoparticles
#2520Use of regulatory T cell-specific surface protein LRIG-1
#2521Peptide nucleic acid complex having improved cell permeability and pharmaceutical composition comprising same
#2522Production of itaconic acid
#2523Algal lipid productivity via genetic modification of a TPR domain containing protein
#2524Exon skipping compositions for treating muscular dystrophy
#2525Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor
#2526Compositions comprising reversibly modified oligonucleotides and uses thereof
#2527Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2528METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2529METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2530METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2531METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2532Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2533Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2534Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2535Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2536Nucleic acids and methods for the treatment of Pompe disease
#2537MODULATION OF TRANSTHYRETIN EXPRESSION
#2538OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF
#2539Antisense antibacterial compounds and methods
#2540Treating metastatic cancer and model systems for metastatic disease
#2541METHODS FOR DETERMINING THE EFFICACY PROFILE OF A DRUG CANDIDATE
#2542Process for formulating an anionic agent
#2543Treatment and prevention of atherothrombosis by inhibition of bruton's tyrosine kinase (BTK)
#2544Allele-specific gene suppression
#2545MODIFIED TGF-BETA OLIGONUCLEOTIDE FOR USE IN A METHOD OF PREVENTING AND/OR TREATING AN OPHTHALMIC DISEASE
#2546MicroRNA Compounds and Methods for Modulating MIR-122
#2547Modulating the cellular stress response
#2548Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#2549STANDARDIZED NEURONAL CELL ASSAYS FROM PRIMATE SPECIES
#2550Nucleic acid molecules encoding antibodies to the human glucagon receptor
#2551Therapy specific, pre-programmed auto injection device
#2552Therapy specific, pre-programmed auto injection device
#2553HPV particles and uses thereof
#2554METHODS OF TREATING DISEASES ASSOCIATED WITH ILC3 CELLS
#2555Pan-genotypic agents against influenza virus and methods of using the same
#2556Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#2557Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
#2558Oligomer-conjugate complexes and their use
#2559Modulating apolipoprotein (a) expression
#2560Compositions and methods for manipulation of adipocyte energy consumption regulatory pathway
#2561GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof
#2562Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases
#2563MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD
#2564SINGLE-STRANDED RNAI OLIGONUCLEOTIDES TARGETING APOC-III
#2565Oligonucleotide analogues targeting human LMNA
#2566Microbial oil containing fatty acids obtained from stramenopile and method of producing the same
#2567Single-stranded oligonucleotide
#2568miRNA for treatment of breast cancer
#2569METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
#2570METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#2571Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotides
#2572EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA)
#2573Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances
#2574METHODS OF USING SMAD7 ANTISENSE OLIGONUCLEOTIDES
#2575METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
#2576Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#2577Oligomers
#2578NOVEL CANCER ANTIGEN EEF2
#2579Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
#2580TEST KIT AND TEST METHOD FOR ATROPHIC AGE-RELATED MACULAR DEGENERATION
#2581Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2582Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2583Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2584Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2585Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2586GNAQ targeted dsRNA compositions and methods for inhibiting expression
#2587METHOD OF PRODUCING INFERTILE FISH AND EGG-PRODUCING AQUATIC ANIMALS AND OF DELIVERING COMPOUNDS INTO EGGS AND EMBRYOS
#2588Methods of Treating Colorectal Cancer
#2589Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53
#2590Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#2591THERAPEUTIC TARGETS FOR LIN-28-EXPRESSING CANCERS
#2592Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#2593Methods for creating bilayers for use with nanopore sensors
#2594Treatment and diagnosis of inflammatory disorders
#2595DNA aptamers specific to CD2000R1 and their therapeutic uses
#2596Antisense antibacterial compounds and methods
#2597Preventing tumor development and metastasis
#2598Antisense oligonucleotides for the treatment of Leber congenital amaurosis
#2599RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
#2600Conjugates enhancing total cellular accumulation
#2601Methods of modulating KEAP1
#2602Enhancing plasmin activity to prevent soft tissue calcification
#2603Modulation of DYRK1B expression
#2604Methods for treating hypercholesterolemia
#2605Therapeutic for treatment of diseases including the central nervous system
#2606Antisense oligomers and uses thereof
#2607Niacinamide (NAM) in ischemic tissue injury
#2608METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2609Compounds for modulating Fc-epsilon-RI-beta expression and uses thereof
#2610Modulation of angiopoietin-like 3 expression
#2611Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#2612Multimeric oligonucleotide compounds
#2613Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#2614Methods and compositions for inhibiting PMP22 expression
#2615Cancer treatment through RLIP76 partial depletion
#2616POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF
#2617Approach for treating inflammatory disorders
#2618ANTISENSE OLIGONUCLEOTIDES FOR MODULATING HTRA1 EXPRESSION
#2619Methods of treating intestinal fibrosis using SMAD7 inhibition
#2620Compositions and Methods For Treating Cachexia
#2621Targeting pleiotrophin signaling to limit high-grade glioma invasion
#2622COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#2623Isolation of extracellular vesicles (EVs) from red blood cells for gene therapy
#2624MODULATORS OF COMPLEMENT FACTOR B
#2625Oligomers
#2626Methods and compositions for plant pest control
#2627Method of treating VEGF/VEGFR resistant prostate cancer by combining the therapy with RAC1 inhibitors
#2628MODULATORS OF KLK3 ERNA
#2629TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#2630Antisense nucleic acids
#2631COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
#2632Targeted RNA editing
#2633Cloning and expression system for T-cell receptors
#2634Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof
#2635Method for decoding base sequence of nucleic acid corresponding to end region of RNA and method for analyzing DNA element
#2636Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#2637COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
#2638Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof
#2639Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
#2640Recombinant virus products and methods for inducing DUX4 exon skipping
#2641Methods and compositions for inhibiting detoxification response
#2642Oligonucleotides
#2643Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
#2644Oligonucleotide compositions with enhanced efficiency
#2645Antisense oligonucleotides for the treatment of Usher syndrome type 2
#2646Methods for modulating Ataxin 2 expression
#2647Compositions and methods for modulating angiopoietin-like 3 expression
#2648Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents
#2649METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2650Monocarboxylate transporter 4 (MCT) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer
#2651Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer
#2652METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2653METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2654METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#2655METHODS FOR REDUCING ATAXIN-2 EXPRESSION
#2656Anti-ADAM33 oligonucleotides and related methods
#2657Methods of treating cancer by inhibition of DNA repair proteins using antisense based therapies
#2658DOUBLE-STRANDED OLIGONUCLEOTIDES
#2659SELECTIVE REDUCTION OF ALLELIC VARIANTS
#2660Oligo-guanidines based cellular transporter comprising heterocyclic rings with hydrophobic and/or lipophilic groups at N-terminal for effective delivery of nonpenetrable cargos in-vitro and in-vivo
#2661Nucleic acid-polypeptide compositions and methods of inducing exon skipping
#2662Compositions and methods for inhibiting HMGB1 expression
#2663Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof
#2664Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#2665Compositions and methods for modulation of IKBKAP splicing
#2666Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#2667Nucleic acid-polypeptide compositions and methods of inducing exon skipping
#2668Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome
#2669AMPHIPHILIC POLYMER MICELLES AND USES THEREOF
#2670METHODS AND COMPOSITIONS FOR CONTROLLING PLANT VIRAL INFECTION
#2671Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#2672Methods for reducing LRRK2 expression
#2673Targeted augmentation of nuclear gene output
#2674Antisense antibacterial compounds and methods
#2675Effective gene therapy tools for dystrophin exon 53 skipping
#2676ANTISENSE MOLECULES FOR TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTION
#2677RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
#2678Enzymatic replacement therapy and antisense therapy for pompe disease
#2679Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#2680Modulation of pre-MRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
#2681Mobilizing leukemia cells
#2682Antisense-induced exon exclusion in myostatin
#2683Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein
#2684ApoCIII and the Treatment and Diagnosis of Diabetes
#2685Serpina1 iRNA compositions and methods of use thereof
#2686Cancer treatment
#2687Methods of reducing expression of X-inactivation escapee genes and autosomal genes
#2688Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
#2689Compositions and their uses directed to huntingtin
#2690IL-34 ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USING SAME
#2691Splice-switching oligonucleotides and methods of use
#2692SPLICE MODULATING OLIGONUCLEOTIDES THAT INHIBIT CANCER
#2693Antitumor drug delivery formulation
#2694CELL PENETRATING MOLECULE
#2695Guayule with increased rubber production and yield
#2696Antisense composition and method for treating muscle atrophy
#2697Antisense Polynucleotides to Induce Exon Skipping and Method of Treating Dystrophies
#2698Nucleic acid nanostructures with core motifs
#2699Composition for preventing or treating keloid or hypertrophic scars
#2700COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION